関連する実験動画

Updated: Sep 3, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 24, 2014

様々な関節炎症の患者のスニョビアル液における甲状腺抗体活性

D R Blake, A M McGregor, E Stansfield

    Lancet (London, England)
    |August 4, 1979
    PubMed
    まとめ

    甲状腺自身抗体は,多くの関節炎患者の関節液に発見されましたが,通常は血液には含まれていません. これは,関節内のこれらの抗体の局所的産生を示し,関節炎の病原性における潜在的な役割を示唆しています.

    さらに関連する動画

    Synovial Fluid Analysis to Identify Osteoarthritis07:51

    Synovial Fluid Analysis to Identify Osteoarthritis

    Published on: October 20, 2022

    A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture08:32

    A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture

    Published on: March 20, 2026

    関連する概念動画

    Myasthenia Gravis: Overview and Treatment01:20

    Myasthenia Gravis: Overview and Treatment

    Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
    These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...